4//SEC Filing
Wong Alvin F 4
Accession 0001437749-22-006180
CIK 0001401667other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 6:50 PM ET
Size
7.0 KB
Accession
0001437749-22-006180
Insider Transaction Report
Form 4
Wong Alvin F
Chief Scientific Officer
Transactions
- Award
Common Stock
2022-03-03+44,882→ 62,034 total - Award
Stock Option (Right to Buy)
2022-03-03+64,118→ 64,118 totalExercise: $2.33Exp: 2032-03-02→ Common Stock (64,118 underlying)
Footnotes (2)
- [F1]Subject to the Grantee's continued service with the Company through the applicable vesting date, the Restricted Stock Units shall vest with respect to one-fourth (1/4th) of the Restricted Stock Units on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024
- [F2]Subject to the Optionee's continued service with the Company through the applicable vesting date, the Option shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares subject thereto on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001868855
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 6:50 PM ET
- Size
- 7.0 KB